January 27th, 2014
How “Compelling” Are Coronary Anatomy and Ischemic Burden When Considering an Invasive Strategy?
William Edward Boden, MD
William E. Boden discusses his research group’s post hoc analysis of data from the COURAGE trial.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?